Yayın: Hemodialysis Experience of a Large Group of Syrian Refugees in Turkey: All Patients Deserve Effective Treatment
item.page.program
Kurum Yazarları
Yazarlar
Gursu, MELTEM
Ates, Kenan
Kazancioglu, RÜMEYZA
Öztürk, Murat
ALTUN, BÜLENT
Arinsoy, Turgay
Danışman
Tarih
2019-01-01
item.page.language
item.page.type
Article
Yayımcı
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
Background/Aims: Refugee dialysis is a worldwide growing dilemma with limited experience.
This report presents the largest hemodialysis (HD) patient registry data of Syrian refugees in
Turkey. Methods: Demographic, clinical, laboratory, and dialysis practice data of 345 Syrian
HD patients during one year were collected and analyzed. Results: There were 345 prevalent
Syrian HD patients at the end of 2016. Majority of the patients were placed in the Southeast
Anatolian Region. The majority of the patients (74.8%) are in the age range of 20-64 years.
Dialysis vintage in Turkey is less than 12 months in 20.8% and less than one month in 29.3%
of patients. The vascular access was arteriovenous fistula in the majority of patients (72.5%).
Kt/V is over 1.7 in 57%, serum albumin is above 35 g/L in 65.8% and hemoglobin level is
more than 100 g/L in %65.2 of the patients. The ratio of patients with serum phosphorus level
of 1.13-1.77 mmol/L was 56.2%. Twenty Syrian HD patients (14 male, 6 female) died within
the year 2016 and annual mortality rate was 5.7%. Conclusion: This study with the largest
number of Syrian refugees undergoing maintenance hemodialysis showed good dialysis
practices, acceptable values for dialysis adequacy and biochemical parameters along with
lower mortality compared to native HD population of Turkey. Longer follow up will enrich the
knowledge related to care of refugee population in all over the world.
Açıklama
item.page.source
item.page.keywords
Konusu
Alıntı
Gursu M., ARICI M., Ates K., Kazancioglu R., Yavas P. G. , Öztürk M., ALTUN B., Arinsoy T., -Hemodialysis Experience of a Large Group of Syrian Refugees in Turkey: All Patients Deserve Effective Treatment-, KIDNEY & BLOOD PRESSURE RESEARCH, cilt.44, ss.43-51, 2019